Royalty Pharma

Royalty Pharma is a private equity investor founded in 1996 that specializes in purchasing rights to royalties on future drug sales. See contact routes.

About Royalty Pharma

Royalty Pharma is a private equity investor founded in 1996 that specializes in purchasing rights to royalties on future drug sales rather than investing in equity. The firm’s investment thesis focuses exclusively on biopharmaceutical royalties, targeting assets that are either approved or in late-stage development across global geographies. Typical transactions involve large check sizes, such as a $900 million royalty purchase from Servier, and the firm consistently acts as a lead buyer in these dedicated royalty deals. Notable portfolio companies include Vertex Pharmaceuticals, whose drug Trikafta is part of Royalty Pharma’s holdings, alongside partial rights to seven of the top 30 selling drugs in the United States. The firm distinguishes itself by providing non-dilutive capital to innovators, including universities and research hospitals, allowing them to fund R&D without equity dilution. Royalty Pharma positions itself as the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the industry, with a portfolio valued at $26.1 billion as of 2026.

Royalty Pharma at a glance

Role
Managing Director
Location
New York, New York, United States
Investor type
Venture Capital

Frequently asked about Royalty Pharma

What does Royalty Pharma invest in?
We have not verified a stated sector or stage focus for Royalty Pharma (New York, New York, United States). The profile lists the organization, location and investors we track alongside them.
How do I contact Royalty Pharma?
Royalty Pharma's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Royalty Pharma headquartered?
Royalty Pharma is based in New York, New York, United States.

StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in New York.

Investors similar to Royalty Pharma (20)

Browse related investor lists (2)

Compare Royalty Pharma (8)

Investors like Royalty Pharma · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades